What is the Correlation between human gut microbiome and diseases

Introduction: The human microbiome is the collection of microbes, their genes, and their products that have colonized our bodies since birth and are transferred vertically. Although all body sites are colonized, the gut, which has been extensively studied, has the highest microbial numbers. Here, we discuss the most important and recent findings regarding the ways in which gut microbes, their activities, and mediator molecules affect our health. The human gut microbiota (GM) is an intricate, dynamic, and spatially heterogeneous environment occupied by a heap of microorganisms cooperating with one another and with the human host, including microscopic organisms, parasites, and archaea, The assortment of all gastrointestinal microorganisms' qualities address a hereditary collection, which is one significant degree higher than that of the human genome. When GM illness occurs, the construction and capability of the gut microbiota will change and cause certain infections. The fundamental administrative components are perplexing. As of late, with the quick improvement of molecular science, genomics, bioinformatics innovation, and high-throughput sequencing innovation, the examination of GM has gained fast headway. A lot of exploration has created proof that GM issues and its metabolites assume a key part in keeping up with digestive homeostasis and impacting the improvement of numerous sicknesses, including neurodegenerative illnesses, cardiovascular sicknesses, metabolic illnesses, and gastrointestinal illnesses. Parkinson’s Disease: Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder that primarily affects the motor system. It is characterized by a loss of dopamine-producing cells in a specific region of the brain called the substantia nigra. Dopamine is a neurotransmitter involved in the control of movement, and its deficiency leads to the motor symptoms associated with Parkinson's. Alpha-synuclein is a protein found in the brain and is associated with the characteristic protein clumps (Lewy bodies) observed in Parkinson's disease. Emerging research suggests that certain bacteria in the gut may promote the misfolding and aggregation of alpha-synuclein. These aggregated proteins can travel from the gut to the brain through different routes, potentially contributing to the development and progression of Parkinson's. The gut microbiota produces various neuroactive substances, including neurotransmitters like dopamine, which is known to be involved in Parkinson's disease. Alterations in the gut microbiota composition can impact the production and metabolism of neurotransmitters, potentially affecting dopamine levels and neurotransmission in the brain. Alzheimer’s Disease: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that primarily affects the brain, leading to a decline in cognitive function and memory. It is the most common cause of dementia, accounting for about 60-80% of all cases. Like other neurodegenerative disorders, an imbalance of the gut-brain axis is the cause of Alzheimer’s disease. Numerous studies have shown a strong connection between GM-induced inflammation and AD. In AD patients, dysbiosis of GM may reduce the number of anti-inflammatory bacteria and increase the number of specific pro-inflammatory bacteria. These Pro-inflammatory gut bacteria taxa produce a lot of metabolites, which can cause peripheral immune cells to invade and cause plasma and central nervous system inflammation to rise. Hypertension: Hypertension is a chronic medical condition characterized by persistently elevated blood pressure in the arteries. It is a widespread health concern affecting a significant portion of the global population. Hypertension is often referred to as the "silent killer" because it usually does not exhibit noticeable symptoms until it reaches advanced stages or causes complications. Changes in gut–nervous system connectivity, altered gut bacterial populations, and altered gut function are all linked to hypertension. Microbial richness, diversity, and evenness were significantly reduced in hypertensive patients. The alteration in the production of microbial metabolites in the gut may be a key mechanism in the regulation of blood pressure, which is largely determined by the intestinal flora. In addition to regulating the intestinal tract itself, GM alters the production of its metabolites, which is how it affects hypertension GM has an effect that goes far beyond just controlling the gut itself. To regulate brain function, GM metabolites can be absorbed into the blood and transported across the blood-brain barrier. Atherosclerosis: Atherosclerosis is a common and progressive disease characterized by the buildup of plaque inside the arteries. It is the leading cause of various cardiovascular diseases, including heart attacks, strokes, and peripheral arterial disease. Over time, the plaque grows and hardens, narrowing the arterial lumen and reducing blood flow. This process is known as stenosis. In advanced stages, the plaque can rupture, causing the formation of a blood clot or thrombus. Evidence of bacterial translocation from the gut to the heart, as well as the presence of both live oral bacteria and bacterial DNA in atherosclerotic plaques, suggest that GM is involved in the onset and progression of atherosclerosis, according to recent research. In the meantime, several studies have shown that intestinal dysbacteriosis in atherosclerosis may raise intestinal permeability, which in turn may raise the amount of lipopolysaccharide absorbed into the bloodstream. As a result, the formation of atherosclerotic plaques may be affected by a distant infection or direct infection of vessel wall cells. Obesity: Obesity is a complex and widespread health issue characterized by an excess accumulation of body fat that negatively impacts an individual's overall well-being. It is a condition that affects people of all ages, ethnicities, and socioeconomic backgrounds, and its prevalence has been steadily increasing worldwide over the past few decades. Obesity and its metabolic complications are major public health problems, more than 1.9 billion adults are overweight and over 650 million adults are obese. Numerous studies have demonstrated that GM is a significant contributor to obesity. Obesity is characterized by GM dysbiosis, which results in a decrease in the diversity and richness of the gut microbiome.  Some of the products of GM fermentation of indigestible carbohydrates prevent obesity by increasing energy consumption and suppressing appetite, while others do so by increasing lipid oxidation. The GM and its metabolites' roles in the onset and progression of obesity have been better understood by the aforementioned studies, which are crucial for obesity treatment and prevention. Diabetes: Insulin resistance, which has the potential to lead to type-2 diabetes (T2D), is linked to obesity caused by a high-fat diet and inflammation. It has been demonstrated that gut bacteria are strongly linked to diabetes, a metabolic disease that has become a global epidemic. Type-1 diabetes (T1D) and type-2 diabetes are the two types of diabetes that are caused by changes in the bacteria in the gut. The event of diabetes is influenced by early digestive microbial colonization upon entering the world, which is impacted by the taking care of ways, birth weight, and the conveyance strategy upon entering the world. Additionally, it was hypothesized that LPS was a novel contributor to the onset of T2D caused by a high-fat diet. Colorectal Cancer: One of the digestive system's most common cancers is colorectal cancer (CRC). CRC has been linked to GM dysbiosis, according to studies. Digestive Microbial Dysbiosis in CRC patients is portrayed by a lessening in the types of gastrointestinal probiotics (like Bifidobacteria, Lactobacillus, and Bacteroides) and an expansion in the quantity of pathogenic microscopic organisms, (for example, Escherichia coli, Bacteroides fragilis, and Fusobacterium nucleatum). The pathogenic microbes discharge harmful synthetics that harm digestive epithelial cells and cause a constant fiery reaction, which is the root cause of CRC. It is also found that Peptostreptococcus anaerobius is exponentially increased in fecal samples and colon growth tissues of patients with CRC, which can enhance the abnormal multiplication of colon cells Inflammatory Bowel Disease: Inflammatory Bowel Disease (IBD) is a chronic disorder characterized by inflammation of the gastrointestinal tract. The two main types of IBD are Crohn's disease and ulcerative colitis, which have similar symptoms but affect different parts of the digestive system. IBD comprising ulcerative colitis and Crohn's is the result of dysregulation of the insusceptible framework prompting digestive aggravation and microbial dysbiosis. There was a lot of evidence to suggest that GM causes intestinal inflammation. A deficiency of gut microbial variety as one of the indications of dysbiosis is generally found in IBD patients. The IBD GM has a significantly lower gut microbial diversity than healthy individuals, as evidenced by a significant increase in Enterobacter and Proteobacteria and a significant decrease in Firmicutes. Liver disease: The gut absorbs beneficial substances produced by the liver. Digestive microflora produces ammonia, ethanol, and acetaldehyde; These products are metabolized by the liver, which also regulates cytokine production and Kupffer cell activity. The seriousness of Concanavalin-A (ConA)- prompted hepatitis is exacerbated when anti-infection agents stifle the flora of the gut. Intestinal micro-organisms that produce hydrogen have been displayed to diminish ConA-actuated aggravation in examinations. Liver damage because of high liquor consumption is likewise connected with dysbiosis of intestinal microbiota. Alcohol-related liver damage and alcohol-induced endotoxemia may be triggered by endotoxins and luminal bacterial metabolites or products. One of the fatal inconveniences of liver illness Hepatic Encephalopathy (HE) is a typical liver sickness. One basic variable for the pathogenesis of HE is the creation of ammonia from amino acids through de-amination by some urease-positive bacteria. Gout: Gout is a purine metabolism disorder-related autoinflammatory disease characterized by elevated blood uric levels. Uric acid crystallization and the accumulation of uric acid crystals in joints, which results in acute pain, are caused by a high blood concentration. Gout patients when inspected showed the presence of Bacteroides caccae and Bacteroides xylanisolvens. In gout patients, the presence of B. caccae triggered severe inflammatory responses. It was discovered that the anti-inflammatory bacteria Faecalibacterium prausnitzii and Bifidobacterium pseudocatenulatum were depleted, affecting the production of butyrate, which is necessary for gut health. Conclusion: We live with an enormous number of microorganisms in our gut. Gut microbiome studies can assume a major part in disease determination through stool examination. Practitioners can use prebiotics, probiotics, and fecal matter transplant to treat chronic diseases like diabetes, IBD, obesity, and others. A promising treatment option may be medications that can alter the composition of the gut microbiome. To determine which component of the microbiome was crucial to the onset of disease, it is necessary to conduct more effective research on the community's structure. The connection between the host and the microbiome isn't all around studied yet. It is important to investigate how the microbiome changes in response to various parameters.